Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Arzerra
Pharma
Novartis to challenge Roche, Sanofi with delayed MS med Kesimpta
In June, the FDA delayed its decision deadline for Novartis MS prospect ofatumumab by three months. But it turns out the agency didn't need that long.
Carly Helfand
Aug 20, 2020 5:29pm
FDA hits Novartis with unexpected delay on MS drug
Jun 3, 2020 11:55am
Novartis' leukemia drug tops Sanofi's Aubagio in MS study
May 27, 2020 10:10am
Which new MS drug do doctors like best? You might be surprised
Nov 19, 2019 11:16am
Novartis' reinvented leukemia drug bests Sanofi's Aubagio in MS
Sep 13, 2019 11:18am
Novartis' Arzerra outpaces Sanofi's Aubagio in MS trial
Aug 30, 2019 9:55am
